The DOI matches its Crossref record.
Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women.
Abstract
Metabolically obese, normal-weight (MONW) individuals are a hypothesized subgroup of the general population. These normal-weight individuals potentially display a cluster of obesity-related features, although this has not been systematically tested in young women. We hypothesized that MONW young women would display higher levels of total and visceral fat and lower levels of physical activity than normal women. In a cohort of 71 healthy nonobese women (21-35 years old), we identified MONW women based on cut points for insulin sensitivity (normal = glucose disposal >8 mg x min(-1) x kg(-1) of fat-free mass [FFM], n = 58; impaired = glucose disposal <8 ml x min(-1) x kg(-1) of FFM, n = 13). Thereafter, we measured body composition (dual energy X-ray absorptiometry) and body fat distribution (computed tomography), cardiorespiratory fitness (VO2max on a treadmill), physical activity energy expenditure (doubly labeled water and indirect calorimetry), glucose tolerance (oral glucose tolerance test), serum lipid profile, and dietary intake. We found a higher body fat percentage (32 +/- 6 vs. 27 +/- 6%, P = 0.01) and higher subcutaneous (213 +/- 61 vs. 160 +/- 78 cm2, P = 0.03) and visceral (44 +/- 16 vs. 35 +/- 14 cm2, P < 0.05) abdominal adiposity in the MONW group versus the normal group. The MONW group showed a lower physical activity energy expenditure (2.66 +/- 0.92 vs. 4.39 +/- 1.50 MJ/day, P = 0.01), but no difference in cardiorespiratory fitness was noted between groups. In conclusion, despite a normal body weight, a subset of young, apparently healthy women displayed a cluster of risky phenotypic characteristics that, if left untreated, may eventually predispose them to type 2 diabetes and cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, as mentioned before, some individuals exhibit the metabolic syndrome with only a moderate degree of total body obesity.43,44”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [44]
In the citing paper
“Moreover, the population of the United States varies considerably in degree of insulin resistance 46 ; those having more inherent insulin resistance can develop the metabolic syndrome with only moderate excess in abdominal fat, 43,44 but even people with little or no inherent insulin resistance can develop the metabolic syndrome if they accumulate marked abdominal obesity.3,8”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [44]
Citations
Cited by
Sorted by citations
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., SULLIVAN, L. M., & D’Agostino, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0594 · Cited by 1,088
“In addition, the criteria defining ATP3 MetS are arbitrary; alternate schemes to define metabolic risk may be equally valid and could produce different results (5, 7, 23).”
BackgroundGreenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Karelis, A. D., St-Pierre, D. H., Conus, F., RABASA-LHORET, R. P. R., & Poehlman, É. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 734
Goodpaster, B. H., Krishnaswami, S., Resnick, H., Kelley, D. E., Haggerty, C., Harris, T. B., Schwartz, A. V., Kritchevsky, S., & Newman, A. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.372 · Cited by 619
Ärnlöv, J., Ingelsson, E., Sundström, J., & Lind, L. (2009) · Circulation · doi:10.1161/circulationaha.109.887521 · Cited by 612
“Systolic blood pressure, mm Hg 129 (16) 137 (18)‡ 134 (17)‡ 142 (18)‡ 139 (18)‡ 148 (21)‡ 0.”
The Concept of Normal Weight Obesity
Oliveros, E., Somers, V. K., Sochor, O., Goel, K., & López-Jiménez, F. A. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.003 · Cited by 628
The metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
“In fact, the metabolic profiles of MHO postmenopausal women are virtually indistinguishable from young lean women (4).”
BackgroundWeight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
Self-citationBrochu, M., Tchernof, A., Dionne, I. J., Sites, C. K., Eltabbakh, G. H., Sims, E. A. H., & Poehlman, E. T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7365 · Cited by 443
Diagnosis and management of the metabolic syndrome
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000200416.65370.a0 · Cited by 437
BMI does not accurately predict overweight in Asian Indians in northern India
Dudeja, V., Misra, A., Pandey, R. M., Devina, G., Kumar, G. S. H., & Vikram, N. K. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001382 · Cited by 372
“This observation is of particular concern, since the incidence of impaired insulin sensitivity reaches about 40 % among those women with percentage BF of .30 (Dvorak et al. 1999), and more than two-thirds of women in the current study belonged to this subgroup.”
BackgroundMuoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372
“In Figure 7 results are presented for the entire cohort grouped together, and after stratifying subjects according to their HOMA-IR upon enrollment, using a conservative cut off of 1.5 (Dvorak et al., 1999).”
MethodInfluentialMokha, J. S., Srinivasan, S. R., DasMahapatra, P., Fernandez, C., Chen, W., Xu, J.-H., & Berenson, G. S. (2010) · BMC Pediatrics · doi:10.1186/1471-2431-10-73 · Cited by 328
“These observations in children are in accordance with the emerging concepts that recognize subsets of obesity and support the existence of metabolically obese normal weight, and metabolically benign obesity phenotypes in adults [2,10,11, 25 ].”
ResultNew obesity classification criteria as a tool for bariatric surgery indication
LORENZO, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 328
Metabolic Syndrome in Normal-Weight Americans
St‐Onge, M., Janssen, I., & Heymsfield, S. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2222 · Cited by 308
“(21) noted greater total, abdominal subcutaneous, and visceral fat and lower physical activity energy expenditure in MONW women despite similar age, BMI, and fat-free mass.”
BackgroundFreedland, E. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-12 · Cited by 303
“The prevalence of MONW could be as high as 13 – 18 percent [26,192,193].”
Poehlman, E. T. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2463 · Cited by 151
“(23) and as previously reported in our laboratory (10, 24).”
BackgroundSelf-citationMetabolically healthy but obese individuals
Karelis, A. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61531-7 · Cited by 269
Normal weight obese (NWO) women: An evaluation of a candidate new syndrome
LORENZO, A. D., Martinoli, R., Vaia, F., & Renzo, L. D. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.010 · Cited by 265
“Central obesity and excessive gain in abdominal fat, correlate closely with both hyperinsulinaemia and insulin resistance and with the possibility of developing type 2 diabetes and coronary heart disease in both obese and metabolically obese individuals [33,34].”
BackgroundHeterogeneity of adipose tissue in development and metabolic function
Schöttl, T., Kapser-Fischer, I., & Ussar, S. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.162958 · Cited by 228
“Since then, these so-called subgroups of ‘metabolically obese’ patients have been studied: the accumulation of fat in VAT has been shown to contribute to metabolic disturbances observed in normal-weight individuals (Dvorak et al., 1999; Ruderman et al., 1998).”
BackgroundMetabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women
Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0265 · Cited by 215
Excess body fat in obese and normal-weight subjects
Thomas, E. L., Frost, G. S., Taylor-Robinson, S. D., & Bell, J. D. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000054 · Cited by 203
“Incidence of ‘metabolically-obese but normal-weight’ has been reported to be between 13 and 18 %((84,102)), which is similar to the incidence of TOFI (12 % women, 14 % men)((7)).”
Characteristics of metabolically obese normal-weight (MONW) subjects
Conus, F., RABASA-LHORET, R. P. R., & Péronnet, F. (2007) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h06-092 · Cited by 208
Edmonton Obesity Staging System: association with weight history and mortality risk
Kuk, J. L., Ardern, C. I., Church, T. S., Sharma, A. M., Padwal, R. S., Sui, X., & Blair, S. N. (2011) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h11-058 · Cited by 214
Metabolic syndrome pathophysiology: The role of adipose tissue
Laclaustra, M., Corella, D., & Ordovás, J. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.10.005 · Cited by 198
Metabolically healthy obesity from childhood to adulthood — Does weight status alone matter?
Blüher, S., & Schwarz, P. E. H. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.009 · Cited by 184
Madeira, F. B., da Sílva, A. A. M., Veloso, H. J. F., Goldani, M. Z., Kac, G., Cardoso, V. C., Bettiol, H., & Barbieri, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060673 · Cited by 186
“Some other studies have reported associations between NWO and metabolic disorders [16,18–27].”
BackgroundMortality, Health Outcomes, and Body Mass Index in the Overweight Range
Lewis, C. E., McTigue, K. M., Burke, L. E., Poirier, P., Eckel, R. H., Howard, B. V., Allison, D. B., Kumanyika, S., & Pi-Sunyer, X. (2009) · Circulation · doi:10.1161/circulationaha.109.192574 · Cited by 189
Vikram, N., Pandey, R., Misra, A., Sharma, R., Devi, J. R., & Khanna, N. (2003) · Nutrition (Burbank, Los Angeles County, Calif.) · doi:10.1016/s0899-9007(02)01083-3 · Cited by 224
MECHANISMS IN ENDOCRINOLOGY: Are metabolically healthy obese individuals really healthy?
Blüher, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0540 · Cited by 174
Brochu, M., Starling, R. D., Tchernof, A., Matthews, D. E., Garcı́a-Rubi, E., & Poehlman, É. T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6685 · Cited by 176
Metabolically healthy but obese women: effect of an energy-restricted diet
Karelis, A. D., Messier, V., Brochu, M., & RABASA-LHORET, R. P. R. (2008) · Diabetologia · doi:10.1007/s00125-008-1038-4 · Cited by 163
“In fact, the metabolic profiles of MHO postmenopausal women are virtually indistinguishable from those of young lean women [3].”
BackgroundSuccurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity · doi:10.1038/oby.2008.308 · Cited by 158
Are there still healthy obese patients?
Blüher, M. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328357f0a3 · Cited by 159
“In accordance with previous studies [17,23,27,40], we found that independently of BMI and total body fat mass, individuals with insulinsensitive obesity had significantly lower visceral fat area, less macrophage infiltration into omental adipose tissue, and smaller adipocyte size both in omental and subcutaneous fat d…”
BackgroundResultIncident Cardiovascular Disease Events in Metabolically Benign Obese Individuals
Ogorodnikova, A. D., Kim, M., McGinn, A. P., Muntner, P., Khan, U. I., & Wildman, R. P. (2011) · Obesity · doi:10.1038/oby.2011.243 · Cited by 146
“Despite inconsistent definitions, previous studies demonstrate a high prevalence of each phenotype: 15–30% of obese are metabolically benign, and 5–18% of normal weight individuals are at-risk (3,6,10,12,13).”
MethodDoes Metabolically Healthy Obesity Exist?
Muñoz‐Garach, A., Cornejo-Pareja, I. M., & Tinahones, F. J. (2016) · Nutrients · doi:10.3390/nu8060320 · Cited by 151
“For example, the intima-media thickness as a risk marker of atherosclerosis is significantly different between individuals with the MHO phenotype and metabolically healthy non-obese patients [5,12,70].”
BackgroundObesity, Abdominal Obesity, and Insulin Resistance
Westphal, S. A. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(08)60025-3 · Cited by 146
Lee, S.-H., Han, K., Yang, H. K., Kim, H. S., Cho, J., Kwon, H.-S., Park, Y.-M., Cha, B. S., & Yoon, K.-H. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2014.46 · Cited by 134
Yu, X., Wang, L., Zhang, W., Ming, J., Jia, A., Xu, S., Li, Q., & Ji, Q. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12975 · Cited by 121
Badoud, F., Perreault, M., Zulyniak, M. A., & Mutch, D. M. (2014) · The FASEB Journal · doi:10.1096/fj.14-263913 · Cited by 131
“(36), who reported increased body fat percentage, as well as higher SAT and VAT abdominal adiposity, in MUNW women compared with LH women.”
BackgroundBiological determinants of spontaneous physical activity
Thorburn, A. W., & Proietto, J. (2000) · Obesity Reviews · doi:10.1046/j.1467-789x.2000.00018.x · Cited by 107
“Normal weight individuals who are metabolically obese, with reduced insulin sensitivity and higher abdominal adiposity, have a 39% lower physical activity energy expenditure than normal women, which may predispose them to weight gain and type 2 diabetes later in life (71).”
BackgroundMetabolically Healthy Obesity—Heterogeneity in Definitions and Unconventional Factors
Brandão, I., Martins, M. J., & Monteiro, R. (2020) · Metabolites · doi:10.3390/metabo10020048 · Cited by 117
Juárez-López, C., Klünder‐Klünder, M., Medina‐Bravo, P., Madrigal-Azcárate, A., Mass-Díaz, E., & Flores‐Huerta, S. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-318 · Cited by 110
Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
Preda, A., Carbone, F., Tirandi, A., Montecucco, F., & Liberale, L. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09813-5 · Cited by 114
Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance
Miles, J. M., & Jensen, M. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2326 · Cited by 102
“sidering that subcutaneous fat stores tend to be increased in individuals who have increased visceral fat mass, even when all of the subjects studied are of normal weight (28).”
BackgroundInfluentialSrinivasan, S. R., Wang, R., Chen, W., Wei, C. Y., Xu, J.-H., & Berenson, G. S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.037 · Cited by 100
Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea
Yang, H. K., Han, K., Kwon, H., Park, Y., Cho, J., Yoon, K., Kang, M., Cha, B., & Lee, S. (2016) · Scientific Reports · doi:10.1038/srep30329 · Cited by 99
Body Composition in Asians and Caucasians
Haldar, S., Chia, S. C., & Henry, C. J. (2015) · Advances in Food and Nutrition Research · doi:10.1016/bs.afnr.2015.07.001 · Cited by 100
Murphy, N., Cross, A. J., Abubakar, M., Jenab, M., Aleksandrova, K., Boutron‐Ruault, M., Dossus, L., Racine, A., Kuhn, T. E., Katzke, V. A., et al. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001988 · Cited by 95
“Hypothesised causes of hyperinsulinaemia in normalweight individuals, beyond an accumulation of visceral fat, may include low physical activity levels [21], low fibre intake [22], and changes in the actions of pro-inflammatory and antiinflammatory cytokines [22,23].”
Shea, J. L., Randell, E. W., & Sun, G. (2010) · Obesity · doi:10.1038/oby.2010.174 · Cited by 94
“Interestingly, the metabolic profile of OB individuals who are metabolically healthy is similar to that of young, lean individuals (10).”
ResultDeterminants of Insulin‐resistant Phenotypes in Normal‐weight and Obese Black African Women
Jennings, C., Lambert, E. V., Collins, M., Joffe, Y. T., Levitt, N. S., & Goedecke, J. H. (2008) · Obesity · doi:10.1038/oby.2008.233 · Cited by 90
Camhi, S. M., Waring, M. E., Sisson, S. B., Hayman, L. L., & Must, A. (2013) · Journal of Obesity · doi:10.1155/2013/984613 · Cited by 92
“Previous studies have employed measures of insulin resistance/sensitivity [1, 7, 53–57], cardiometabolic clustering [9], adiposity [58– 60], or a combination [6, 9, 61].”
MethodPhysical Activity, Obesity Status, and Glycemic Control
Kavouras, S. A., Panagiotakos, D. B., Pitsavos, C. E., Chrysohoou, C. A., Anastasiou, C. A., Lentzas, Y., & Stefanadis, C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31803084eb · Cited by 93
Metabolic Obesity in People with Normal Body Weight (MONW)—Review of Diagnostic Criteria
Pluta, W. W., Dudzińska, W., & Lubkowska, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020624 · Cited by 97
“On the other hand, in other studies in non-obese patients with an excessive accumulation of fat, no atherogenic lipid profile, differences in blood pressure values [18,19] or in the concentration of adipocytokines [14,15] were observed.”
BackgroundResultGaida, J. E., Cook, J. L., & Bass, S. L. (2008) · Disability and Rehabilitation · doi:10.1080/09638280701786864 · Cited by 89
Shapira, N. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-1 · Cited by 90
Yoo, H. J., Hwang, S. Y., Hong, H. C., Choi, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., Baik, S. H., & Choi, K. M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.02.033 · Cited by 78
“reported that physical activity energy expenditure was significantly lower (412 kcal lower) in the MANW group compared to the MHNW group [33].”
ResultIs Visceral Adiposity the “Enemy Within”?
Tracy, R. P. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.881 · Cited by 81
Jung, Y., Han, K., Park, H. L., Lee, S., & Park, C. K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0048 · Cited by 77
Metabolically healthy obese individuals: Key protective factors
Gonçalves, C. G., Glade, M. J., & Meguid, M. M. (2015) · Nutrition · doi:10.1016/j.nut.2015.07.010 · Cited by 75
Sangachin, M. G., Cavuoto, L. A., & Wang, Y. (2018) · BMC Obesity · doi:10.1186/s40608-018-0205-5 · Cited by 80
“These “metabolically obese but normal weight” [21] individuals share many health risks with those categorized as obese both based on BMI and %BF [22].”
BackgroundIs insulin resistance the cause of the metabolic syndrome?
Ferrannini, E. (2006) · Annals of Medicine · doi:10.1080/07853890500415358 · Cited by 74
“Physical activity, on the other hand, is a strong determinant of insulin sensitivity (46) and cardiorespiratory fitness is a potent predictor of metabolic and cardiovascular risk (47,48).”
BackgroundPrevalence and Clinical Profile of Metabolic Obesity and Phenotypic Obesity in Asian Indians
Geetha, L., Deepa, M., Anjana, R. M., & Mohan, V. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500235 · Cited by 75
Nyholm, B., Nielsen, M. F., Kristensen, K., Nielsen, S., Ostergard, T., Pedersen, S. B., Christiansen, T., Richelsen, B., Jensen, M., & Schmitz, O. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500207 · Cited by 72
Perseghin, G., Scifo, P., Danna, M., Battezzati, A., Benedini, S., Meneghini, E., Maschio, A. D., & Luzi, L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00127.2002 · Cited by 69
Metabolic Syndrome and Cardiometabolic Risk Factors
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 67
Brochu, M., Tchernof, A., Turner, A. N., Ades, P. A., & Poehlman, É. T. (2003) · Metabolism · doi:10.1053/meta.2003.50095 · Cited by 69
Self-citationLee, S., Ha, H., Park, Y., Lee, J., Yim, H., Yoon, K., Kang, M., Lee, W., Son, H., Park, Y., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04085.x · Cited by 68
Life Years Lost Associated with Obesity-Related Diseases for U.S. Non-Smoking Adults
Chang, S., Pollack, L. M., & Colditz, G. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066550 · Cited by 73
“5, 25); overweight if BMI M [25, 30); class I obese if BMI M [30, 35), class II obese if BMI M [35, 40), and class III obese if BMI is at least 40 kg/m(2).”
BackgroundFactors that may impede the weight loss response to exercise‐based interventions
Boutcher, S. H., & Dunn, S. L. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00621.x · Cited by 73
“However, IR is one of the earliest manifestations of metabolic syndrome and has been found in young adults free of other metabolic abnormalities such as dyslipidemia, high blood pressure, high fasting blood glucose levels and abdominal obesity (57).”
BackgroundSleep deprivation and energy metabolism: to sleep, perchance to eat?
Penev, P. D. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282be9093 · Cited by 66
Shin, C. M., Han, K., Lee, D. H., Choi, Y. J., Kim, N., Park, Y. S., & Yoon, H. (2017) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000876 · Cited by 63
Excess accumulation of body fat is related to dyslipidemia in normal-weight subjects
Ito, H., Nakasuga, K., Ohshima, A., Sakai, Y., Maruyama, T., Kaji, Y., Harada, M., Jingu, S., & Sakamoto, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802528 · Cited by 64
Hamilton, O. K., Zhang, Q., McRae, A. F., Walker, R. M., Morris, S. W., Redmond, P. H., Campbell, A., Murray, A. D., Porteous, D. J., Evans, K. L., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-018-0262-3 · Cited by 50
Changes in Metabolic Health Status Over Time and Risk of Developing Type 2 Diabetes
Lee, S., Yang, H. K., Ha, H., Lee, J., Kwon, H., Park, Y., Yim, H., Kang, M., Lee, W., Son, H., et al. (2015) · Medicine · doi:10.1097/md.0000000000001705 · Cited by 60
Severe Periodontitis Is Associated with Insulin Resistance in Non-abdominal Obese Adults
Song, I., Han, K., Park, Y., Ji, S., Jun, S.-H., Ryu, J., & Park, J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2061 · Cited by 60
Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Teixeira, T. F., Alves, R. D. M., Moreira, A. P. B., & Pelúzio, M. D. C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu007 · Cited by 61
Peppa, Μ., Koliaki, C. C., Papaefstathiou, A., Garoflos, E., Katsilambros, N. L., Raptis, S., Hadjidakis, D. I., & Dimitriadis, G. (2013) · Obesity · doi:10.1002/oby.20227 · Cited by 58
“Our findings add to the existing strong evidence that central adiposity is a prominent body composition factor, which is associated with ‘‘metabolically obese’’ phenotypes, irrespective of BMI (4-6,12,34).”
BackgroundResultBåvenholm, P., Kuhl, J., Pigon, J., Saha, A. K., Ruderman, N. B., & Efendić, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020330 · Cited by 59
“(32) recently reported that young normalweight and insulin-resistant women have increased total and visceral fat, compared with control women of similar weight and BMI but normal insulin sensitivity.”
BackgroundPrevalence of metabolic syndrome in normal weight individuals
Suliga, E., Kozieł, D., & Głuszek, S. (2016) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1226858 · Cited by 60
Shaharyar, S., Roberson, L. L., Jamal, O. S., Younus, A., Blaha, M. J., Ali, S. S., Zide, K., Agatston, A. A., Blumenthal, R. S., Conceição, R., et al. (2015) · Journal of Obesity · doi:10.1155/2015/178526 · Cited by 57
“The aim of this study was to explore the association amongMHO, MUNW, and markers of subclinical CVD burden as assessed by high sensitivity C-reactive protein (CRP) and hepatic steatosis (HS) in individuals without overt CVD.”
InfluentialChoi, J., Se-Young, O., Lee, D., Tak, S. K., Hong, M., Park, S., Cho, B., & Park, M. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.09.001 · Cited by 59
“[6] reported that MONW women had a similar proportion of fat-free mass, but had a higher proportion of total fat mass and body fat percentage compared to metabolically healthy, normal weight (MHNW) women.”
Insulin resistance and metabolic syndrome in normal-weight individuals
Chen, S., Chen, Y., Liu, X., Li, M., Wu, B., Li, Y., Liang, Y., Shao, X., Holthöfer, H., & Zou, H. (2013) · Endocrine · doi:10.1007/s12020-013-0079-8 · Cited by 56
The ESHRE/ASRM consensus on polycystic ovary syndrome (PCOS) – an extended critical analysis
Geisthövel, F., & Rabe, T. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60902-9 · Cited by 56
“but normal weight (MONW)’ individuals (Ruderman et al., 1998; Dvorak et al., 1999; St-Onge et al., 2004; Meigs et al., 2006) and ‘metabolically normal but obese (MNO)’”
BackgroundBo, S., Musso, G., Gambino, R., Villois, P., Gentile, L., Durazzo, M., Cavallo‐Perin, P., & Cassader, M. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.040006 · Cited by 52
“The following effects have been reported as putative contributors to insulin resistance in NW subjects: reduced physical activity, lower peak oxygen uptake, less dietary restraint (4, 39), increased accumulation of visceral adipose tissue (2, 16, 39, 40), low fiber intake (41), high concentrations of free fatty acids…”
BackgroundAgius, R., Pace, N. P., & Fava, S. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3725 · Cited by 64
“14,22,30,51,52 Again, the use of consensus criteria to define MH should help to remove definition ‐ related variability.”
BackgroundIs adiposity at normal body weight relevant for cardiovascular disease risk?
Tanaka, S., Togashi, K., Rankinen, T., Përusse, L., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801880 · Cited by 54
Normal weight dyslipidemia: Is it all about the liver?
Ipsen, D. H., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2016) · Obesity · doi:10.1002/oby.21443 · Cited by 51
“However, generally applied features of NWD include dyslipidemia and increased blood glucose, waist circumference, and BMI when compared with controls (42-51).”
BackgroundInfluentialLee, J., Lee, H. C., Shim, J., Im, J., Kim, S., Choi, H.-A., & Lee, D. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02780.x · Cited by 49
Catov, J. M., Newman, A. B., Roberts, J. M., Sutton‐Tyrrell, K., Kelsey, S. F., Harris, T. B., Jackson, R., Colbert, L. H., Satterfield, S., Ayonayon, H. N., et al. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.02.007 · Cited by 49
Bervoets, L., & Massa, G. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0395 · Cited by 47
“However, it has previously been shown that the MUO phenotype also occurs in normalweight individuals and that a higher degree of obesity in children and adolescents is not always associated with a higher prevalence of prediabetes and/or the metabolic syndrome [19, 27].”
BackgroundCho, Y. G., Song, H. J., Kim, J. M., Park, K., Paek, Y., Cho, J. J., Caterson, I. D., & Kang, J. G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.01.004 · Cited by 47
Tanrıkulu-Kılıç, F., Bekpınar, S., Ünlüçerçi, Y., & Orhan, Y. (2006) · Physiological Research · doi:10.33549/physiolres.930745 · Cited by 45
Chen, S., Chen, Y., Liu, X., Li, M., Wu, B., Li, Y., Liang, Y., Shao, X., Holthöfer, H., & Zou, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074058 · Cited by 44
“Apart from fat mass and fat distribution, dietary, physical inactivity, genetic factors are associated with IR in non-obese individuals [1,18].”
BackgroundTanaka, S., Togashi, K., Rankinen, T., Përusse, L., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., Després, J., & Bouchard, C. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802545 · Cited by 43
Kim, D., Nam, S.-Y., Ahn, C. W., Kim, K., Yoon, S., Kim, J., Cha, B., Lim, S., Kim, K.-R., Lee, H., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1825 · Cited by 42
“Moreover, visceral adipose tissue is well recognized to be significantly related to insulin resistance of obese type 2 diabetic patients and even patients with normal weight (4,5).”
BackgroundJeor, S. T. S., Hayman, L. L., Daniels, S. R., Gillman, M. W., Howard, G., Law, C., Lewis, C. E., & Poehlman, É. T. (2004) · Circulation · doi:10.1161/01.cir.0000140092.48032.d2 · Cited by 44
Avolio, E., Gualtieri, P., Romano, L., Pecorella, C., Ferraro, S., Palma, G., Di Renzo, L., & De Lorenzo, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190326113607 · Cited by 43
Metabolic Syndrome Pathophysiology
Das, U. N. (2010) · Wiley eBooks · doi:10.1002/9780813820637 · Cited by 44
Metadata
- Authors
- Dvorak, R. V., DeNino, W. F., Ades, P. A., & Poehlman, E. T.
- Affiliations
- Department of Medicine, College of Medicine, University of Vermont, Burlington 05405, USA.
- University of Vermont (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1999-11-01
- Volume
- 48
- Issue
- 11
- Pages
- 2210-2214
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2155025864
- Cited by
- 243
- References
- 0
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 4 · 2019: 10 · 2018: 15 · 2017: 8 · 2016: 16 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 17
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag015114-03)
- National Institute on Aging (R01-AG15114)
- National Institute of Dental and Craniofacial Research (DE 950226)
- National Center for Research Resources (RR-00109)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, visceral fat, subcutaneous abdominal fat, physical activity energy expenditure, cardiorespiratory fitness, body composition, glucose tolerance, type 2 diabetes risk, cardiovascular risk, young women
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Blood Pressure, Body Constitution, Body Weight, Contraceptives, Oral, Diabetes Mellitus, Female, Glucose, Humans, Obesity, Phenotype, Reference Values, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review